Clinical Trials Browser

Phase 1/2 × Lymphoma, T-Cell, Peripheral × pembrolizumab × Clear all

NCT06137144 2026-05-19

PRIMAVERA

Phase 1/2 Recruiting

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral

NCT02535247 2022-07-08

Study of MK-3475 Alone or in Combination With Copanlisib in Relapsed or Refractory NK and T-cell Non-Hodgkin Lymphoma

Phase 1/2 Terminated

17 enrolled 7 charts

Lymphoma, T-Cell, Peripheral